Chlorpheniramine maleate 0.2 MG/ML / dextromethorphan hydrobromide 1.5 MG/ML Oral Solution — RxCUI 1111440
RxNorm drug concept · Semantic clinical drug
RxCUI 1111440
Semantic clinical drug · SCD
● Current RxNorm concept 11 FDA products
11 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1111440
Official nameChlorpheniramine maleate 0.2 MG/ML / dextromethorphan hydrobromide 1.5 MG/ML Oral Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known aschlorpheniramine maleate 1 MG / dextromethorphan hydrobromide 7.5 MG per 5 ML Oral Solution; chlorpheniramine maleate 1 MG / dextromethorphan HBr 7.5 MG in 5 mL Oral Solution; chlorpheniramine maleate 2 MG / dextromethorphan hydrobromide 15 MG per 10 ML Oral Solution
FDA products mapped11
Package NDCs mapped11
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Dextromethorphan: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- It's a cough suppressant. It temporarily relieves cough from minor throat and bronchial irritation, like with a cold or inhaled irritants. Some products also help you sleep by calm...
- It depends on the product. Extended-release suspensions like Delsym are labeled for every 12 hours, while Giltuss Honey DM Cough is every 6 to 8 hours with a 4-dose daily limit. Ch...
- Be careful. Don't use it if you take a prescription MAOI, or within 2 weeks of stopping one. If you're not sure whether your medicine is an MAOI, ask me or your doctor before takin...
- Nighttime products can cause marked drowsiness, and children may become excitable. Avoid alcohol and be careful driving.
🕸️ Concept Web — How Chlorpheniramine maleate 0.2 MG/ML / dextrometho... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Chlorpheniramine maleate 0.2 MG/ML / dextromethorphan hydrobromide 1.5 MG/ML Oral Solution
RxCUI 1111440 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 5
The active substance itself — no strength, form, or brand attached yet.
-
Chlorpheniramine
2400IN -
Dextromethorphan
3289IN -
Chlorpheniramine / dextromethorphan
214390MIN -
Chlorpheniramine maleate
142429PIN -
Dextromethorphan hydrobromide
102490PIN
-
Chlorpheniramine
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Chlorpheniramine / dextromethorphan Oral Solution
371456SCDF -
Chlorpheniramine maleate / dextromethorphan hydrobromide Oral Solution
2645924SCDFP -
Chlorpheniramine / dextromethorphan Oral Liquid Product
1154179SCDG -
Chlorpheniramine / dextromethorphan Oral Product
1154180SCDG -
Chlorpheniramine maleate / dextromethorphan hydrobromide Oral Liquid Product
2659718SCDGP -
Chlorpheniramine maleate / dextromethorphan hydrobromide Oral Product
2659774SCDGP -
Oral Solution
316968DF -
Oral Liquid Product
1151137DFG - +1 more in this family
-
Chlorpheniramine / dextromethorphan Oral Solution
-
Clinical & branded drugs 2
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Chlorpheniramine maleate 0.2 MG/ML
1038875SCDC -
Dextromethorphan hydrobromide 1.5 MG/ML
1090505SCDC
-
Chlorpheniramine maleate 0.2 MG/ML
-
Packs 2
Fixed collections of drugs packaged and sold together, like dose packs.
-
{1 (chlorpheniramine maleate 0.2 MG/ML / dextromethorphan hydrobromide 1.5 MG/ML Oral Solution) / 1 (dextromethorphan hydrobromide 1 MG/ML / guaifenesin 10 MG/ML Oral Solution) } Pack
2362250GPCK -
{1 (chlorpheniramine maleate 0.2 MG/ML / dextromethorphan hydrobromide 1.5 MG/ML Oral Solution) / 1 (dextromethorphan hydrobromide 1 MG/ML / guaifenesin 20 MG/ML Oral Solution) } Pack
2119625GPCK
-
{1 (chlorpheniramine maleate 0.2 MG/ML / dextromethorphan hydrobromide 1.5 MG/ML Oral Solution) / 1 (dextromethorphan hydrobromide 1 MG/ML / guaifenesin 10 MG/ML Oral Solution) } Pack
Showing up to 8 concepts per family — 17 of 18 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
{1 (chlorpheniramine maleate 0.2 MG/ML / dextromethorphan hydrobromide 1.5 MG/ML Oral Solution) / 1 (dextromethorphan hydrobromide 1 MG/ML / guaifenesin 10 MG/ML Oral Solution) } Pack
GPCK · 2362250 -
{1 (chlorpheniramine maleate 0.2 MG/ML / dextromethorphan hydrobromide 1.5 MG/ML Oral Solution) / 1 (dextromethorphan hydrobromide 1 MG/ML / guaifenesin 20 MG/ML Oral Solution) } Pack
GPCK · 2119625 -
Chlorpheniramine maleate 0.2 MG/ML
SCDC · 1038875 -
Dextromethorphan hydrobromide 1.5 MG/ML
SCDC · 1090505 -
Chlorpheniramine / dextromethorphan Oral Solution
SCDF · 371456 -
Chlorpheniramine maleate / dextromethorphan hydrobromide Oral Solution
SCDFP · 2645924 -
Chlorpheniramine / dextromethorphan Oral Liquid Product
SCDG · 1154179 -
Chlorpheniramine / dextromethorphan Oral Product
SCDG · 1154180 -
Chlorpheniramine maleate / dextromethorphan hydrobromide Oral Liquid Product
SCDGP · 2659718 -
Chlorpheniramine maleate / dextromethorphan hydrobromide Oral Product
SCDGP · 2659774
📦 FDA Products & Package NDCs
11 products · 11 package NDCs
11 package NDCs map to RxCUI 1111440 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00031-2099-01 | 1 KIT in 1 CARTON (0031-2099-01) * 1 BOTTLE in 1 CARTON (0... | Robitussin Day and Night Cough Relief Value Pack | Haleon US Holdings LLC | 2020-05-12 |
| 00031-8692-13 | 1 BOTTLE in 1 CARTON (0031-8692-13) / 118 mL in 1 BOTTLE | Childrens Robitussin Nighttime Cough Long-Acting DM | Haleon US Holdings LLC | 2014-07-01 |
| 00031-8693-12 | 1 BOTTLE in 1 CARTON (0031-8693-12) / 118 mL in 1 BOTTLE | CHILDRENS ROBITUSSIN COUGH AND COLD LONG-ACTING | Haleon US Holdings LLC | 2004-01-01 |
| 00363-7560-04 | 118 mL in 1 BOTTLE (0363-7560-04) | Walgreens Childrens | WALGREENS CO. | 2019-07-16 |
| 00363-7570-08 | 1 KIT in 1 KIT (0363-7570-08) * 118 mL in 1 BOTTLE (0363-7... | Walgreens DAY and NIGHT PACK | WALGREEN CO | 2020-04-13 |
| 24286-1551-04 | 1 BOTTLE in 1 BOX (24286-1551-4) / 118 mL in 1 BOTTLE | Bactimicina Childrens Cough and Cold | DLC Laboratories, Inc. | 2009-10-23 |
| 51316-0745-04 | 1 BOTTLE in 1 CARTON (51316-745-04) / 118 mL in 1 BOTTLE | CVS childrens Cough and Cold | CVS PHARMACY | 2023-02-17 |
| 55319-0754-04 | 1 BOTTLE in 1 CARTON (55319-754-04) / 118 mL in 1 BOTTLE | Childrens Cough and Cold | FAMILY DOLLAR SERVICES INC | 2023-05-08 |
| 69676-0088-09 | 1 BOTTLE in 1 CARTON (69676-0088-9) / 118 mL in 1 BOTTLE | Nighttime Cough-Kids | Genexa | 2025-05-06 |
| 69676-0110-09 | 2 BOTTLE, PLASTIC in 1 BOX (69676-0110-9) / 1 KIT in 1 BOTT... | Kids Daytime Cough and Nighttime Cough combo pack | Genexa Inc. | 2026-03-20 |
| 69842-0657-08 | 1 KIT in 1 KIT (69842-657-08) * 118 mL in 1 BOTTLE * 118... | Daytime and Nighttime Cough and Chest Congestion Childrens | CVS Pharmacy | 2019-02-19 |
Observed labelers:
Haleon US Holdings LLC (3) ·
CVS Pharmacy (2) ·
DLC Laboratories, Inc. (1) ·
FAMILY DOLLAR SERVICES INC (1) ·
Genexa (1) ·
Genexa Inc. (1)
· +2 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.